Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Chaudhuri

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
The Medical Clinics of North America|August 17, 2004
Endothelial dysfunction and hypertension in diabetes mellitusParesh Dandona, Ajay Chaudhuri, Ahmad Aljada
Journal of Clinical Hypertension (Greenwich, Conn.)|December 6, 2018
Liraglutide and systolic blood pressureParesh Dandona, Husam Ghanim, Ajay Chaudhuri
JAMA|May 29, 2008
Glucose-insulin-potassium therapy in patients with STEMIAjay Chaudhuri, Richard Nesto, Paresh Dandona
JAMA|August 21, 2008
Insulin therapy and lipid overload in type 2 diabetesParesh Dandona, Ajay Chaudhuri, Husam Ghanim
The New England Journal of Medicine|September 6, 2023
Semaglutide in Early Type 1 DiabetesParesh Dandona, Ajay Chaudhuri, Husam Ghanim
Diabetes, Obesity & Metabolism|November 15, 2021
Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trialsAjay Chaudhuri, Husam Ghanim, Pradeep Arora
Diabetes Care|March 2, 2010
Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk: response to wannamethee et AlHusam Ghanim, Ajay Chaudhuri, Paresh Dandona
JAMA|September 6, 2012
Glucose-insulin-potassium for suspected acute myocardial infarctionAjay Chaudhuri, Richard Nesto, Paresh Dandona
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Cardiovascular benefits of exogenous insulinAjay Chaudhuri, Paresh Dandona, Vivian Fonseca
The New England Journal of Medicine|January 17, 2024
More on Semaglutide in Early Type 1 Diabetes. ReplyParesh Dandona, Ajay Chaudhuri, Husam Ghanim
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
The Medical Clinics of North America|August 17, 2004
Endothelial dysfunction and hypertension in diabetes mellitusParesh Dandona, Ajay Chaudhuri, Ahmad Aljada
Journal of Clinical Hypertension (Greenwich, Conn.)|December 6, 2018
Liraglutide and systolic blood pressureParesh Dandona, Husam Ghanim, Ajay Chaudhuri
JAMA|May 29, 2008
Glucose-insulin-potassium therapy in patients with STEMIAjay Chaudhuri, Richard Nesto, Paresh Dandona
JAMA|August 21, 2008
Insulin therapy and lipid overload in type 2 diabetesParesh Dandona, Ajay Chaudhuri, Husam Ghanim
The New England Journal of Medicine|September 6, 2023
Semaglutide in Early Type 1 DiabetesParesh Dandona, Ajay Chaudhuri, Husam Ghanim
Diabetes, Obesity & Metabolism|November 15, 2021
Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trialsAjay Chaudhuri, Husam Ghanim, Pradeep Arora
Diabetes Care|March 2, 2010
Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk: response to wannamethee et AlHusam Ghanim, Ajay Chaudhuri, Paresh Dandona
JAMA|September 6, 2012
Glucose-insulin-potassium for suspected acute myocardial infarctionAjay Chaudhuri, Richard Nesto, Paresh Dandona
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Cardiovascular benefits of exogenous insulinAjay Chaudhuri, Paresh Dandona, Vivian Fonseca
The New England Journal of Medicine|January 17, 2024
More on Semaglutide in Early Type 1 Diabetes. ReplyParesh Dandona, Ajay Chaudhuri, Husam Ghanim
Pageof 12